EPSTEIN-BARR VIRUS INFECTION

Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear

Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 3 Completed 1

Could this vaccine stop the 'Kissing Disease' and its Long-Term risks?

⭐️ VACCINE ⭐️ Completed

This study tested a new vaccine designed to prevent Epstein-Barr virus (EBV) infection, which causes mononucleosis and is linked to certain cancers and autoimmune diseases. The trial involved 25 healthy adults aged 18 to 25 who had never had EBV. Participants received either the …

Matched conditions: EPSTEIN-BARR VIRUS INFECTION

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️

Last updated May 11, 2026 20:49 UTC

EPSTEIN-BARR VIRUS INFECTION

Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear

Could this vaccine stop the 'Kissing Disease' and its Long-Term risks?